Back to TCRX
GOLDMAN SACHS GROUP INC → TCRX
GOLDMAN SACHS GROUP INC TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
11
Latest value
$19K
Q3 2026
Peak value
$575K
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $575K |
| Q2 2025 | $48K |
| Q3 2025 | $169K |
| Q3 2025 | $69K |
| Q4 2025 | $20K |
| Q4 2025 | $67K |
| Q4 2025 | $67K |
| Q4 2025 | $20K |
| Q1 2026 | $38K |
| Q2 2026 | $69K |
| Q3 2026 | $19K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $19K | 59.7K | — | — |
| Q2 2026 | $69K | 70.5K | — | — |
| Q1 2026 | $38K | 37.3K | — | — |
| Q4 2025 | $20K | 20.3K | — | — |
| Q4 2025 | $67K | 66.7K | — | — |
| Q4 2025 | $67K | 66.7K | — | — |
| Q4 2025 | $20K | 20.3K | — | — |
| Q3 2025 | $69K | 38.0K | — | — |
| Q3 2025 | $169K | 93.0K | — | — |
| Q2 2025 | $48K | 33.4K | — | — |
| Q2 2025 | $575K | 396.7K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M